Trial Profile
Long-term efficacy of ivabradine in patients with chronic heart failure and preserved left ventricular systolic function
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Oct 2015
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Chronic heart failure
- Focus Pharmacodynamics; Therapeutic Use
- 29 Oct 2015 Results presented at ESC Congress 2015: Annual Congress of the European Society of Cardiology
- 29 Oct 2015 New trial record